Product
Relugolix Combination
1 clinical trial
2 indications
Indication
Uterine FibroidsIndication
EndometriosisClinical trial
A Phase 3B, Single-Arm, Open-Label Study to Evaluate Bone Mineral Density With Long-Term Use of Relugolix Combination Tablet in Premenopausal Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids or Moderate to Severe Pain Associated With EndometriosisStatus: Recruiting, Estimated PCD: 2029-07-01